Immune System

Scancell, Celltech team up on new cancer target

07-Aug-2003

Scancell and Celltech are to collaborate on the development of
novel monoclonal antibody therapeutics targeting Lewis y/b, a new
cancer target.

Cobra signs cancer vaccine production deal

06-Aug-2003

Cobra Biomanufacturing has signed an agreement to supply Advaxis
with clinical and commercial supplies of its Listeria
monocytogenes-based cancer vaccine.

Symphogen strengthens Ab patent position

10-Jul-2003

Danish biotech company Symphogen has obtained a European patent on
its Symphage technology for the development of antibody-based
drugs. Clinical trials of the product candidate are due to start in
2005.

Investing in peptides

17-Apr-2003

US company PPD is taking a stake in Chemokine Therapeutics, a
Canadian- and US-based biotechnology company, to continue
development of a proprietary peptide derived from a particular
chemokine that may make the peptide useful as a...